Molecular modelling of human PATCHED-1 may incentivize development of novel therapies for advanced basal cell carcinoma

被引：0
|
作者：
Hernandez, J. [1 ]
Kim, M. [1 ]
Kulkarni, V. [2 ]
Goode, M. A. [1 ]
Graham, S. [1 ]
Lane, M. P. [1 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN USA
[2] Univ Queensland, Coll Med, Brisbane, Qld, Australia
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
824
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 20 条
  • [1] Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma
    Russell-Goldman, Eleanor
    MacConaill, Laura
    Hanna, John
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (04) : 266 - 272
  • [2] Spectrum of mutations in the tumor-suppressor gene, patched-1, in patients with nevoid basal cell carcinoma syndrome
    Miyashita, T.
    NEURO-ONCOLOGY, 2007, 9 (02) : 183 - 183
  • [3] Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma
    Hoashi, Toshihiko
    Kanda, Naoko
    Saeki, Hidehisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [4] Novel Patched 1 mutations in patients with nevoid basal cell carcinoma syndrome - case report
    Skodric-Trifunovic, Vesna
    Stjepanovic, Mihailo
    Savic, Zivorad
    Ilic, Miroslav
    Kavecan, Ivana
    Privrodski, Jadranka Jovanovic
    Spasovski, Vesna
    Stojiljkovic, Maja
    Pavlovic, Sonja
    CROATIAN MEDICAL JOURNAL, 2015, 56 (01) : 63 - 67
  • [5] Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies
    Ruiz Salas, Veronica
    Alegre, Marta
    Ramon Garces, Joan
    Puig, Lluis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (06) : 741 - 749
  • [6] Development of a novel molecular therapeutic target for advanced renal cell carcinoma (RCC)
    Sim, M. Y.
    Sim, H. G.
    Chong, T. W.
    Lau, W. K. O.
    Cheng, C. W. S.
    Yuen, J. S. P.
    Huynh, H.
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A359 - A359
  • [7] The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    CURRENT ONCOLOGY, 2023, 30 (01) : 610 - 640
  • [8] Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies
    Fadlullah, Muhammad Zaki Hidayatullah
    Chiang, Ivy Kim-Ni
    Dionne, Kalen R.
    Yee, Pei San
    Gan, Chai Phei
    Sam, Kin Kit
    Tiong, Kai Hung
    Ng, Adrian Kwok Wen
    Martin, Daniel
    Lim, Kue Peng
    Kallarakkal, Thomas George
    Mustafa, Wan Mahadzir Wan
    Lau, Shin Hin
    Abraham, Mannil Thomas
    Zain, Rosnah Binti
    Rahman, Zainal Ariff Abdul
    Molinolo, Alfredo
    Patel, Vyomesh
    Gutkind, J. Silvio
    Tan, Aik Choon
    Cheong, Sok Ching
    ONCOTARGET, 2016, 7 (19) : 27802 - 27818
  • [9] In vitro modelling of basal cell carcinoma reveals a novel PTCH1-GLI1 signalling axis that is independent of SMOOTHENED in human keratinocytes
    Rahman, M. M.
    Kelsell, D. P.
    Philpott, M. P.
    Neill, G. W.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (04) : 907 - 908
  • [10] In vitro modelling of basal cell carcinoma reveals a novel PTCH1-GLI1 signalling axis that is unresponsive to Smoothened inhibitors in human keratinocytes
    Rahman, M.
    Herath, D.
    Selway, J.
    Roy, A.
    Nadendla, S.
    Kelsell, D.
    Harwood, C.
    Philpott, M.
    Neill, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : e29 - e29
12